- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04246944
Induced Membrane Properties in Children and Adults (EMIH)
March 21, 2023 updated by: Centre Hospitalier Universitaire, Amiens
Bone reconstruction in critical sized defect (CSD) remains a real challenge in orthopedic surgery in children and adults.
The Masquelet technique is an innovative therapeutic technique, which offers a bone reconstruction in two steps, by the formation of an induced membrane (IM) around a polymethylmethacrylate (PMMA) spacer placed into the bone defect.
After, PMMA removal, the cavity is filled with corticocancellous graft allowing bone healing.
Up to date, all angiogenesis and osteogenic properties of IM remain unknown.
The purpose of this study is to characterize angiogenesis and osteogenic properties of IM in children and adults.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Céline Klein, MD
- Phone Number: (33)322087571
- Email: klein.celine@chu-amiens.fr
Study Locations
-
-
-
Amiens, France, 80054
- Recruiting
- CHU Amiens
-
Contact:
- Céline Klein, MD
- Phone Number: (33)322087571
- Email: klein.celine@chu-emaine.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 months to 60 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All patients treated at CHU Amiens-Picardie for bone critical sized defect treated using the induced membrane reconstruction technique.
- patients from 9 months to 60 years old
Exclusion Criteria:
- Patients managed by another reconstruction technique for critical sized defect
- Patients under guardianship, curators or deprived of liberty.
- Pregnant and nursing women.
- Patients who refused to participate in the study and to sign informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measure of the BMP2 concentration of the induced membrane by immunodetection
Time Frame: one year (one year from day of surgery)
|
Measure of the osteogenic property of the induced membrane will be made after harvesting the induced membrane
|
one year (one year from day of surgery)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
BMP2 concentration of the induced membrane implanted in adults measured by immunodetection
Time Frame: one year (one year from day of surgery)
|
measurement of osteogenic property of the induced membrane in adults
|
one year (one year from day of surgery)
|
BMP2 concentration of the induced membrane implanted in children measured by immunodetection
Time Frame: one year (one year from day of surgery)
|
measurement of osteogenic property of the induced membrane in children
|
one year (one year from day of surgery)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Céline Klein, MD, CHU Amiens
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 23, 2019
Primary Completion (Anticipated)
January 1, 2030
Study Completion (Anticipated)
January 1, 2030
Study Registration Dates
First Submitted
January 17, 2020
First Submitted That Met QC Criteria
January 28, 2020
First Posted (Actual)
January 29, 2020
Study Record Updates
Last Update Posted (Actual)
March 22, 2023
Last Update Submitted That Met QC Criteria
March 21, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PI2018_843_0041
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
3MRecruitingAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Maquet Cardiopulmonary GmbHNAMSARecruitingCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain
-
Baylor Research InstituteChiesi USA, Inc.RecruitingSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Surgify Medical OyCompletedSurgery | Spine SurgeryFinland
-
Cairo UniversityBatterjee Medical College; Taif UniversityCompletedSurgery | Bariatric SurgeryEgypt, Saudi Arabia
-
Poudre Valley Health SystemTerminatedSurgery | Surgery--ComplicationsUnited States
Clinical Trials on harvesting induced membrane
-
University of MilanCompletedGingival Recession | Palate; WoundItaly
-
Medical University InnsbruckRecruitingCoronary Artery DiseaseAustria, Germany, Switzerland
-
Boston Scientific CorporationHerzzentrum DresdenTerminatedCoronary Artery DiseaseGermany
-
Meshalkin Research Institute of Pathology of CirculationCompletedAutovenous Conduit for Coronary Artery Bypass Grafting
-
Kerckhoff KlinikCompletedCABG Graft IntegrityGermany
-
China National Center for Cardiovascular DiseasesUnknown
-
Seoul National University HospitalCompletedMyocardial Infarction | Stable Angina | Unstable Angina | Triple Vessel DiseaseKorea, Republic of
-
Beijing Anzhen HospitalBeijing Municipal Administration of HospitalsUnknownCoronary Artery Disease | Graft FailureChina
-
Azienda Ospedaliera San Giovanni BattistaLivaNovaUnknownCoronary Artery Bypass Grafting SurgeryItaly
-
Second Affiliated Hospital, School of Medicine,...West China Hospital; Tongji Hospital; Werner Wicker KlinikRecruiting